Racial Disparities in Breast Cancer: from Detection to Treatment

Purpose of Review Update on current racial disparities in the detection and treatment of breast cancer. Recent Findings Breast cancer remains the leading cause of cancer death among Black and Hispanic women. Mammography rates among Black and Hispanic women have surpassed those among White women, wit...

Full description

Saved in:
Bibliographic Details
Published in:Current oncology reports 2024-01, Vol.26 (1), p.10-20
Main Authors: Chen, JC, Stover, Daniel G., Ballinger, Tarah J., Bazan, Jose G., Schneider, Bryan P., Andersen, Barbara L., Carson, William E., Obeng-Gyasi, Samilia
Format: Article
Language:English
Subjects:
Asian Americans
Biopsy
Black people
Breast cancer
Cancer screening
Cancer therapies
Chemotherapy
Drug therapy
Endocrine therapy
Genetic screening
Genetic testing
Hispanic people
Inequality
Internal medicine
Lymphatic system
Mammography
Mastectomy
Medical screening
Medicine
Medicine & Public Health
Oncology
Race
Racial differences
Radiation
Reconstructive surgery
Surgery
Topical Collection on Breast Cancer
Toxicity
White people
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of Review Update on current racial disparities in the detection and treatment of breast cancer. Recent Findings Breast cancer remains the leading cause of cancer death among Black and Hispanic women. Mammography rates among Black and Hispanic women have surpassed those among White women, with studies now advocating for earlier initiation of breast cancer screening in Black women. Black, Hispanic, Asian, and American Indian and Alaskan Native women continue to experience delays in diagnosis and time to treatment. Further, racial discrepancies in receipt of guideline-concordant care, access to genetic testing and surgical reconstruction persist. Disparities in the initiation, completion, toxicity, and efficacy of chemotherapy, endocrine therapy, and targeted drug therapy remain for racially marginalized women. Summary Efforts to evaluate the impact of race and ethnicity across the breast cancer spectrum are increasing, but knowledge gaps remain and further research is necessary to reduce the disparity gap.
ISSN:1523-3790
1534-6269
DOI:10.1007/s11912-023-01472-8